DGIdb - THIORIDAZINE Drug Record

THIORIDAZINE chembl:CHEMBL479

Alternate Names:

MELLERIL
MELLARIL
RIDERIL
TP-21
MELLARIL-S
THIORIDAZINE
THIORIDAZIN
MEL269
TIORIDAZINA
THIORIDAZINUM
3-METHYLMERCAPTO-N-(2'-(N-METHYL-2-PIPERIDYL)ETHYL)PHENOTHIAZINE
MELLARIL®
10-[2-(1-METHYL-2-PIPERIDYL)ETHYL]-2-METHYLSULFANYL-PHENOTHIAZINE
2-METHYLMERCAPTO-10-(2-(N-METHYL-2-PIPERIDYL)ETHYL)PHENOTHIAZINE
chemidplus:50-52-2
chembl:CHEMBL479
drugbank:00679
rxcui:10502
pubchem.compound:5452

Drug Info:

Drug Class	antipsychotic agents
Year of Approval	1962
FDA Approval	1962
Drug Class	small molecule
Drug Indications	Antipsychotic Agents

(4 More Sources)

Publications:

Tay JK et al., 2007, Functional polymorphisms of the cytochrome P450 1A2 (CYP1A2) gene and prolonged QTc interval in schizophrenia., Prog Neuropsychopharmacol Biol Psychiatry
Lee CA et al., 2010, Identification of novel substrates for human cytochrome P450 2J2., Drug Metab Dispos
von Bahr C et al., 1991, Plasma levels of thioridazine and metabolites are influenced by the debrisoquin hydroxylation phenotype., Clin Pharmacol Ther
Dorado P et al., 2009, Relevance of CYP2D6 -1584C>G polymorphism for thioridazine:mesoridazine plasma concentration ratio in psychiatric patients., Pharmacogenomics
Hammock et al., 1995, The effect of clozapine on self-injurious behavior., J Autism Dev Disord
Milnes et al., 2006, hERG K+ channel blockade by the antipsychotic drug thioridazine: An obligatory role for the S6 helix residue F656., Biochem. Biophys. Res. Commun.
Katchman AN et al., 2006, Comparative evaluation of HERG currents and QT intervals following challenge with suspected torsadogenic and nontorsadogenic drugs., J Pharmacol Exp Ther
Canton et al., 1994, Competitive antagonism of serotonin (5-HT)2C and 5-HT2A receptor-mediated phosphoinositide (PI) turnover by clozapine in the rat: a comparison to other antipsychotics., Neurosci. Lett.
Costall et al., 1995, Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations., Br. J. Pharmacol.
Morisset et al., 1999, Atypical neuroleptics enhance histamine turnover in brain via 5-Hydroxytryptamine2A receptor blockade., J. Pharmacol. Exp. Ther.
Andree et al., 1986, Differential effect of subchronic treatment with various neuroleptic agents on serotonin2 receptors in rat cerebral cortex., J. Neurochem.
Burki, 1986, Binding of psychoactive drugs to rat brain amine receptors, measured ex vivo, and their effects on the metabolism of biogenic amines., Naunyn Schmiedebergs Arch. Pharmacol.
Sleight et al., 1993, Binding of antipsychotic drugs at alpha 1A- and alpha 1B-adrenoceptors: risperidone is selective for the alpha 1B-adrenoceptors., Eur. J. Pharmacol.
Cahir et al., 2005, Antipsychotics lack alpha 1A/B adrenoceptor subtype selectivity in the rat., Eur Neuropsychopharmacol
Seeman, 1990, Atypical neuroleptics: role of multiple receptors, endogenous dopamine, and receptor linkage., Acta Psychiatr Scand Suppl
Carey et al., 1997, Discriminative-stimulus effects of clozapine in squirrel monkeys: comparison with conventional and novel antipsychotic drugs., Psychopharmacology (Berl.)
Assié et al., 1993, Biphasic displacement of [3H]YM-09151-2 binding in the rat brain by thioridazine, risperidone and clozapine, but not by other antipsychotics., Eur. J. Pharmacol.
Barth et al., 2006, Comparison of rat dopamine D2 receptor occupancy for a series of antipsychotic drugs measured using radiolabeled or nonlabeled raclopride tracer., Life Sci.
Dimpfel et al., 1992, Different neuroleptics show common dose and time dependent effects in quantitative field potential analysis in freely moving rats., Psychopharmacology (Berl.)

THIORIDAZINE CYP2J2

Interaction Score: 0.82

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
19923256

Sources:
PharmGKB
THIORIDAZINE HTR2A

Interaction Score: 0.33

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

Trial Name -

PMIDs:
7898773 8680734 9918563 2866233 2423886

Sources:
TdgClinicalTrial ChemblInteractions TEND
THIORIDAZINE DRD2

Interaction Score: 0.22

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

Mechanism of Interaction D2-like dopamine receptor antagonist

PMIDs:
1978482 9292626 7689973 16434058 1352051

Sources:
TdgClinicalTrial ChemblInteractions TEND TTD
THIORIDAZINE ADRA1A

Interaction Score: 0.19

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
7691623 15695070

Sources:
TdgClinicalTrial TEND
THIORIDAZINE DRD1

Interaction Score: 0.11

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Novel drug target Established target

Trial Name -

PMIDs:
8720030

Sources:
DTC TdgClinicalTrial TEND
THIORIDAZINE DRD4

Interaction Score: 0.1

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Direct Interaction yes

Mechanism of Interaction D2-like dopamine receptor antagonist

PMIDs:
None found

Sources:
ChemblInteractions
THIORIDAZINE HTR2C

Interaction Score: 0.08

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2c (5-HT2c) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
THIORIDAZINE DRD3

Interaction Score: 0.06

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction D2-like dopamine receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
THIORIDAZINE KCNH2

Interaction Score: 0.04

Interaction Types & Directionality:

inhibitor (inhibitory)

Interaction Info:

PMIDs:
17056009 16278312

Sources:
PharmGKB
THIORIDAZINE PPARD

Interaction Score: 0.03

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC
THIORIDAZINE CYP2D6

Interaction Score: 0.03

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
2007317 19604081

Sources:
PharmGKB FDA
THIORIDAZINE CBX1

Interaction Score: 0.02

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC
THIORIDAZINE ATXN2

Interaction Score: 0.02

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC
THIORIDAZINE CYP1A2

Interaction Score: 0.01

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
17611010

Sources:
PharmGKB
THIORIDAZINE EHMT2

Interaction Score: 0.0

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC

TEND: THIORIDAZINE
- Version: 01-August-2011
Alternate Names:

THIORIDAZINE Primary Drug Name

Drug Info:

Year of Approval 1962

Drug Class antipsychotic agents

Publications:
TdgClinicalTrial: THIORIDAZINE
- Version: January-2014
Alternate Names:

Drug Info:

Drug Indications Antipsychotic Agents

Drug Class small molecule

FDA Approval 1962

Publications:

PharmGKB: thioridazine

Version: 18-August-2020

Alternate Names:

Drug Info:

Publications:

Tay JK et al., 2007, Functional polymorphisms of the cytochrome P450 1A2 (CYP1A2) gene and prolonged QTc interval in schizophrenia., Prog Neuropsychopharmacol Biol Psychiatry

Lee CA et al., 2010, Identification of novel substrates for human cytochrome P450 2J2., Drug Metab Dispos

Dorado P et al., 2009, Relevance of CYP2D6 -1584C>G polymorphism for thioridazine:mesoridazine plasma concentration ratio in psychiatric patients., Pharmacogenomics

DTC: THIORIDAZINE
- Version: 02-September-2020
Alternate Names:

CHEMBL479 ChEMBL Drug ID

Drug Info:

Publications:
TTD: Thioridazine
- Version: 2020.06.01
Alternate Names:

D0U1OE TTD Drug ID

Drug Info:

Publications:
ChemblDrugs: chembl:CHEMBL479
- Version: ChEMBL_27
Alternate Names:

Drug Info:

Publications:
FDA: Thioridazine
- Version: 04-September-2020
Alternate Names:

Drug Info:

Publications:
ChemblInteractions: CHEMBL479
- Version: chembl_23
Alternate Names:

Drug Info:

Publications:

Mechanism of Interaction	Serotonin 2a (5-HT2a) receptor antagonist
Direct Interaction	yes
Trial Name	-

Trial Name	-
Novel drug target	Established target
Mechanism of Interaction	D2-like dopamine receptor antagonist

Mechanism of Interaction	Serotonin 2c (5-HT2c) receptor antagonist
Direct Interaction	yes

THIORIDAZINE Drug Record

THIORIDAZINE chembl:CHEMBL479

Alternate Names:

Drug Info:

Publications:

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 19923256

Sources: PharmGKB

Interaction Types & Directionality: antagonist (inhibitory)

Interaction Info: Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist Direct Interaction yes Trial Name -

PMIDs: 7898773 8680734 9918563 2866233 2423886

Sources: TdgClinicalTrial ChemblInteractions TEND

Interaction Types & Directionality: antagonist (inhibitory)

Interaction Info: Trial Name - Novel drug target Established target Mechanism of Interaction D2-like dopamine receptor antagonist

PMIDs: 1978482 9292626 7689973 16434058 1352051

Sources: TdgClinicalTrial ChemblInteractions TEND TTD

Interaction Types & Directionality: antagonist (inhibitory)

Interaction Info: Trial Name - Novel drug target Established target

PMIDs: 7691623 15695070

Sources: TdgClinicalTrial TEND

Interaction Types & Directionality: antagonist (inhibitory)

Interaction Info: Novel drug target Established target Trial Name -

PMIDs: 8720030

Sources: DTC TdgClinicalTrial TEND

Interaction Types & Directionality: antagonist (inhibitory)

Interaction Info: Direct Interaction yes Mechanism of Interaction D2-like dopamine receptor antagonist

PMIDs: None found

Sources: ChemblInteractions

Interaction Types & Directionality: antagonist (inhibitory)

Interaction Info: Mechanism of Interaction Serotonin 2c (5-HT2c) receptor antagonist Direct Interaction yes

PMIDs: None found

Sources: ChemblInteractions

Interaction Types & Directionality: antagonist (inhibitory)

Interaction Info: Mechanism of Interaction D2-like dopamine receptor antagonist Direct Interaction yes

PMIDs: None found

Sources: ChemblInteractions

Interaction Types & Directionality: inhibitor (inhibitory)

Interaction Info:

PMIDs: 17056009 16278312

Sources: PharmGKB

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: None found

Sources: DTC

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 2007317 19604081

Sources: PharmGKB FDA

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: None found

Sources: DTC

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: None found

Sources: DTC

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 17611010

Sources: PharmGKB

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: None found

Sources: DTC

TEND: THIORIDAZINE

Alternate Names: THIORIDAZINE Primary Drug Name

Drug Info: Year of Approval 1962 Drug Class antipsychotic agents

Publications:

TdgClinicalTrial: THIORIDAZINE

Alternate Names:

Drug Info: Drug Indications Antipsychotic Agents Drug Class small molecule FDA Approval 1962

Publications:

PharmGKB: thioridazine

Alternate Names:

Drug Info:

DTC: THIORIDAZINE

Alternate Names: CHEMBL479 ChEMBL Drug ID

Drug Info:

Publications:

Interaction Types & Directionality:

n/a

PMIDs:
19923256

Sources:
PharmGKB

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2a (5-HT2a) receptor antagonist

Direct Interaction yes

Trial Name -

PMIDs:
7898773 8680734 9918563 2866233 2423886

Sources:
TdgClinicalTrial ChemblInteractions TEND

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

Mechanism of Interaction D2-like dopamine receptor antagonist

PMIDs:
1978482 9292626 7689973 16434058 1352051

Sources:
TdgClinicalTrial ChemblInteractions TEND TTD

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
7691623 15695070

Sources:
TdgClinicalTrial TEND

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Novel drug target Established target

Trial Name -

PMIDs:
8720030

Sources:
DTC TdgClinicalTrial TEND

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Direct Interaction yes

Mechanism of Interaction D2-like dopamine receptor antagonist

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction Serotonin 2c (5-HT2c) receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Mechanism of Interaction D2-like dopamine receptor antagonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

inhibitor (inhibitory)

PMIDs:
17056009 16278312

Sources:
PharmGKB

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
DTC

Interaction Types & Directionality:

n/a

PMIDs:
2007317 19604081

Sources:
PharmGKB FDA

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
DTC

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
DTC

Interaction Types & Directionality:

n/a

PMIDs:
17611010

Sources:
PharmGKB

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
DTC

Alternate Names:

THIORIDAZINE Primary Drug Name

Drug Info:

Year of Approval 1962

Drug Class antipsychotic agents

Drug Info:

Drug Indications Antipsychotic Agents

Drug Class small molecule

FDA Approval 1962

Alternate Names:

CHEMBL479 ChEMBL Drug ID

Alternate Names:

D0U1OE TTD Drug ID